InvestorsHub Logo
icon url

FALCON1

10/14/17 1:37 PM

#4642 RE: bow-tie #4641

Just to be clear here. Mymetics' contract to manufacture Imugene's Herr-vax vaccine no longer in effect since 2015 after Imugene decided to use a different formulation/approach for their vaccine. And one of the links you provided leads them to go the other route.

This is the patent of the formulation the're using now:PCT/AU2016/050275, ‘A vaccine composition and uses thereof’, claims the specific P467-CRM197 plus Montanide adjuvant vaccine formulation commencing a Phase Ib clinical trial in 2016.

Good find...thanks
icon url

GuiNoir

10/14/17 4:55 PM

#4646 RE: bow-tie #4641

First a big thank-you to you and HH and Corpus for all your posts.

With the Moser article , I was wondering if the question he asked, "No licensed virosomal vaccines after 2014?" has an answer now?

And Moser also referred to, "The Vaccine Dilemma." I don't understand what he meant by that.

Thanks